The true incidence of thrombosis among people who received targeted therapy for breast cancer is significantly higher than ...

Combining ultraviolet (UV) phototherapy with the Janus kinase (JAK) inhibitor baricitinib (Olumiant) helped patients with ...

Prostate cancer remains one of the most prevalent cancers among men worldwide. For patients with advanced or metastatic ...

Vigil Neuroscience reported a strong safety profile and 50% sTREM2 reduction in an early-stage trial for VG-3927, potentially ...

A panelist discusses how she carefully transitions patients to neurokinin-targeted therapies by establishing realistic timelines for symptom improvement and actively monitoring patient response while ...

A pair of abstracts presented at the 2024 American Society of Hematology (ASH) Annual Meeting & Exhibition suggest that ...

A new therapy for the most aggressive type of brain cancer can extend patients' survival while cutting the length of ...

A targeted therapy is one that has been developed to affect a specific target, such as an enzyme or receptor. Targeted therapies can either block or increase the function of their target in order ...

Although the sales of both types of these drugs are expanding, the majority of sales growth is attributed to an increasing uptake of targeted cancer therapies. In 2009, US sales of targeted ...

In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...

You’ll likely have a few cancer treatment options. Your doctor may recommend chemo, hormone, or targeted therapy. Sometimes you may receive a combination of therapies, or something else entirely.